Search alternatives:
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
5 c » 25 c (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
5 c » 25 c (Expand Search)
-
241
-
242
-
243
-
244
-
245
-
246
-
247
-
248
-
249
The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans
Published 2017“…</p><p>Methods</p><p>A single oral dose of oseltamivir at 75 mg was administered to 20 healthy subjects, 8 heterozygous c.662A>G carriers (c.662AG) and 12 non-carriers (c.662AA). …”
-
250
-
251
-
252
-
253
-
254
-
255
-
256
Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice.
Published 2022“…Similarly, BACE1, LAMP1 and LC3B-II/ LC3B-I were also increased in nimodipine-treated 5XFAD compared to nimodipine treated non-transgenic mice, indicating that nimodipine did not decrease the accumulation of these dystrophic neurite marker proteins. …”
-
257
Administration of APB5, but not APA5, decreases the hyperplasia of alveolar type 2 epithelial cells induced by BLM.
Published 2018“…The BLM treatment induced hyperplasia and increased the number of SP-C-positive type 2 epithelial cells. The administration of APB5 markedly decreased the hyperplasia of type 2 epithelial cells induced by BLM. …”
-
258
The 5’SS motif decreases mRNA stability and promotes nuclear retention.
Published 2015“…Note that the relative level of <i>c-ftz-Δi-V5-His</i> decreases over the first 60 min until 40–50% of the mRNA remains, after which point the ratio is stable. …”
-
259
Annual number of outpatient visits in recurrence and non-recurrence groups.
Published 2025“…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
-
260